Multicenter Tolvaptan study For Uncontrolled volume overload in Japanese acute decompensated heart failure patients: A prospective observational multicenter cohort study
Phase of Trial: Phase III
Latest Information Update: 13 Apr 2018
At a glance
- Drugs Tolvaptan (Primary)
- Indications Decompensated heart failure
- Focus Adverse reactions; Therapeutic Use
- Acronyms MT FUJI
- 10 Jun 2017 Biomarkers information updated
- 01 Jun 2017 Status changed from active, no longer recruiting to completed.
- 29 Dec 2016 Planned End Date changed to 31 Jan 2017.